This webinar includes key points to consider prior to prescribing menopausal hormone therapy (MHT), including treatment options, analysis of benefits and risks, and potential side effects.
Last updated: 22 September 2020
| Last reviewed: 30 March 2017
Learning objectives
- Identify contraindications to HRT/MHT, with particular attention to breast cancer risk and venous thrombo-embolic event (VTE) risk
- Discuss treatment options for HRT/MHT
- Outline correct dosages and potential side effects of HRT/MHT (patient safety)
- Discuss the cessation of HRT/MHT and non-hormonal treatment options
RACGP QI&CPD Program
This webinar is activity number 185299. It is accredited with 2 category 2 CPD points.
NOTE: This is a Category 2 activity, and does not count towards a GP's RANZCOG accreditation.
Download the RACGP feedback form.
Health professional
- MHT position statement
- Jean Hailes Menopause health professional tool
- Greene Climacteric Scale for menopause symptoms
- CAM use and menopause
- AMS Guide to Equivalent HRT Doses
Patient information
Jean Hailes for Women's Health
Evaluation
To receive a certificate of completion and/or RACGP QI&CPD points, complete the evaluation survey below: